{"OMIM ID": "OMIM:230600", "DISEASE": "Gm1-gangliosidosis, Type Ii", "RECORD": "Rare disease patients have complex clinical representations. Patients with Gm1-gangliosidosis, Type Ii present clinical features that include developmental delay, seizures, and ataxia. This disease is caused by mutations in the GM1A gene, which encodes the lysosomal enzyme beta-galactosidase.\n\nThe objective of this study was to describe the clinical and genetic features of patients with Gm1-gangl. Some special cases also present with the symptoms of other diseases, such as epilepsy, autism, and schizophrenia.\n\nThe study included 15 patients with Gm1-gangliosidosis, Type II, and their families. The clinical and genetic features of these patients were described.\n\nThe study included 15 patients with Gm1-gangliosidosis, Type II, and their families. The clinical and genetic features of these patients were described.\n\nThe study included 15 patients with Gm1-gangliosidosis, Type II, and their families. The clinical and genetic features of these patients were described.\n\nThe study. The main symptomatic differences of Gm1-gangliosidosis, Type Ii from similar diseases is that the patients with Gm1-gangliosidosis, Type Ii present with ataxia, seizures, and developmental delay.\n\nThe study. The main symptomatic differences of Gm1-gangliosidosis, Type Ii from similar diseases is that the patients with Gm1-", "SUMMARY": "gangliosidosis, Type Ii present with ataxia, seizures, and developmental delay.\n\nThe study. The main symptomatic differences of Gm1-gangliosidosis, Type Ii from similar diseases is that"}